Clinical Pediatric Pneumonia Score in Critically Ill Children
| Status: | Withdrawn |
|---|---|
| Conditions: | Pneumonia, Hospital |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases, Other |
| Healthy: | No |
| Age Range: | Any - 21 |
| Updated: | 4/26/2017 |
| Start Date: | August 2012 |
| End Date: | January 2013 |
Development of a Clinical Pediatric Pneumonia Score in Critically Ill Children Admitted With Acute Respiratory Failure
The purpose of the study is to create a clinical pneumonia tool that can be used to predict
the cause of community-acquired pneumonia, which is a lung infection that began outside of
the hospital in critically ill children therefore limiting unnecessary antibiotic use. The
investigators will enroll critically ill children admitted with acute respiratory failure
and suspected pneumonia. Each patient will receive a clinical pneumonia score blinded from
culture and respiratory viral panel results. All care after samples obtained will be at the
discretion of the PICU team. The investigators believe that our clinical pneumonia scale
with procalcitonin will accurately designate viral from bacterial etiologies.
the cause of community-acquired pneumonia, which is a lung infection that began outside of
the hospital in critically ill children therefore limiting unnecessary antibiotic use. The
investigators will enroll critically ill children admitted with acute respiratory failure
and suspected pneumonia. Each patient will receive a clinical pneumonia score blinded from
culture and respiratory viral panel results. All care after samples obtained will be at the
discretion of the PICU team. The investigators believe that our clinical pneumonia scale
with procalcitonin will accurately designate viral from bacterial etiologies.
Inclusion Criteria:
- All intubated pediatric patients
- Age 1 day to 21 years
- Admitted to the LLUCH PICU with suspected pneumonia for the next 6 months
- Have received antibiotics for less than 12 hours
- Have been intubated for less than 24 hours
- Patients must be English or Spanish speaking for consent purposes.
Exclusion Criteria:
- Patients who have received antibiotics for greater than 12 hours
- Patients who have been intubated for greater than 24 hours
- Patients who are unable to tolerate non-bronchoscopic bronchoalveolar lavage
We found this trial at
1
site
Click here to add this to my saved trials
